NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Public ClinicalTrials.gov record NCT01733121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of NBI-98854 (titrated to a subject's optimal dose in the range of 25 to 75 mg) administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.
Study identification
- NCT ID
- NCT01733121
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2012 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Aug 10, 2017
2012 – 2013
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Englewood | Colorado | 80113 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Miami | Florida | 33125 | — |
| Not listed | Chicago | Illinois | 60640 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Farmington Hills | Michigan | 48334 | — |
| Not listed | Beachwood | Ohio | 44122 | — |
| Not listed | Middleburg Heights | Ohio | 44130 | — |
| Not listed | Conshohocken | Pennsylvania | 19428 | — |
| Not listed | Phoenixville | Pennsylvania | 19460 | — |
| Not listed | Bedford | Texas | 76021 | — |
| Not listed | DeSoto | Texas | 75115 | — |
| Not listed | Houston | Texas | 77008 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Irving | Texas | 75062 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01733121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2017 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01733121 live on ClinicalTrials.gov.